Carregant...
OP04. Predicting sites of treatment failure and tumour recurrence in the invasive margin of glioblastomas (PRaM-GBM) - Trial
AIM: The invasive nature of glioblastomas ensures that residual disease is inevitable following surgery. As this cannot be identified with conventional imaging, radiotherapy volumes must include normal brain to treat this occult invasion. We need an imaging biomarker to identify this residual tumour...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358556/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now292.003 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|